propranolol has been researched along with Syndrome in 122 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Of these 11 (not taking propranolol), nine (82 percent) developed postsurgical dissatisfaction syndrome." | 9.14 | Preventing postsurgical dissatisfaction syndrome after rhinoplasty with propranolol: a pilot study. ( Gruber, RP; Pitman, RK; Roberts, C; Schooler, W, 2009) |
| "Dextromethorphan, a noncompetitive blocker of the N-methyl-D-aspartate (NMDA) type of glutamate receptor, at 45, 60 and 75 mg/kg, ip doses induced a behavioural syndrome characterised by reciprocal forepaw treading, lateral head-weaving, hind-limb abduction and flat body posture." | 7.73 | Involvement of central serotonergic systems in dextromethorphan-induced behavioural syndrome in rats. ( Balsara, JJ; Gaikwad, RV; Gaonkar, RK; Jadhav, JH; Jadhav, SA; Thorat, VM, 2005) |
| "Baroreflex sensitivity was measured by the heart rate response to the transient rise in blood pressure induced by phenylephrine, in 11 patients with carotid sinus syndrome, 6 patients with sick sinus syndrome and nine age and blood pressure matched controls." | 7.67 | Baroreflex sensitivity measured by the phenylephrine pressor test in patients with carotid sinus and sick sinus syndromes. ( Chan, SL; Dehn, TC; Morley, CA; Perrins, EJ; Sutton, R, 1984) |
| "A serum sickness-like syndrome developed in a 38-year-old woman with a history of drug allergy who had been taking propranolol hydrochloride (Inderal) for four days." | 7.66 | Serum sickness-like syndrome associated with propranolol therapy. ( Mintzer, DL; Piszczek, JE; Yen, MC, 1983) |
| " Exacerbating factors, including diuretic-induced hypokalemia and the concomitant administration of perphenazine, were present." | 7.65 | Asymptomatic idiopathic syndrome of prolonged Q-T interval in a 45-year-old woman. Ventricular tachyarrhythmias precipitated by hypokalemia and therapy with amitriptyline and prephenazine. ( Bahler, A; Pincus, J; Schneider, RR; Stimmel, B, 1977) |
| "Prior to propranolol the systemic treatment for haemangiomas was prednisolone and then the concern was the opposite, namely hypertension." | 5.42 | Propranolol and prednisolone combination for the treatment of segmental haemangioma in PHACES syndrome. ( Batul Syed, S; Gnarra, M; Harper, J; Solman, L, 2015) |
| "PHACE syndrome is a neurocutaneous disorder with large facial segmental hemangionas associated with anomalies of the brain, eye, heart and aorta." | 5.37 | Use of propranolol for treatment of hemangiomas in PHACE syndrome. ( Deming, D; Hopper, A; Merritt, TA; Ninnis, J; Solomon, T, 2011) |
| " Of these 11 (not taking propranolol), nine (82 percent) developed postsurgical dissatisfaction syndrome." | 5.14 | Preventing postsurgical dissatisfaction syndrome after rhinoplasty with propranolol: a pilot study. ( Gruber, RP; Pitman, RK; Roberts, C; Schooler, W, 2009) |
| "The main purpose of this study was to describe a unique case of retro-orbital infantile hemangioma (IH) simulating a congenital glaucoma requiring prompt management with systemic propranolol." | 3.91 | Secondary Congenital Glaucoma Associated With Retro-orbital Infantile Hemangioma: A Masquerade Syndrome. ( Beylerian, M; Dambricourt, L; Denis, D; Matonti, F; Ramtohul, P, 2019) |
| " We measured the effects of a selective blocker of I(T) (ethosuximide) in healthy subjects on the amplitude and frequency of saccadic oscillations evoked by eye closure and of a nonselective blocker of I(h) and I(T) (propronolol) in a patient with microsaccadic oscillation and limb tremor syndrome (mSOLT)." | 3.77 | The effects of ion channel blockers validate the conductance-based model of saccadic oscillations. ( Leigh, RJ; Miura, K; Optican, LM; Ramat, S; Shaikh, AG; Zee, DS, 2011) |
| "Dextromethorphan, a noncompetitive blocker of the N-methyl-D-aspartate (NMDA) type of glutamate receptor, at 45, 60 and 75 mg/kg, ip doses induced a behavioural syndrome characterised by reciprocal forepaw treading, lateral head-weaving, hind-limb abduction and flat body posture." | 3.73 | Involvement of central serotonergic systems in dextromethorphan-induced behavioural syndrome in rats. ( Balsara, JJ; Gaikwad, RV; Gaonkar, RK; Jadhav, JH; Jadhav, SA; Thorat, VM, 2005) |
| "Patients with abdominal migraine may benefit from prophylactic treatment with propranolol or cyproheptadine." | 3.70 | Abdominal migraine: prophylactic treatment and follow-up. ( Lichtman, SN; Rhoads, JM; Ulshen, MH; Worawattanakul, M, 1999) |
| "The mechanisms by which imipramine and dihydroergosine stimulate the 5-HT syndrome in rats and inhibit the head-twitch response in rats and mice were studied." | 3.68 | Do imipramine and dihydroergosine possess two components--one stimulating 5-HT1 and the other inhibiting 5-HT2 receptors? ( Mück-Seler, D; Pericić, D, 1990) |
| "Baroreflex sensitivity was measured by the heart rate response to the transient rise in blood pressure induced by phenylephrine, in 11 patients with carotid sinus syndrome, 6 patients with sick sinus syndrome and nine age and blood pressure matched controls." | 3.67 | Baroreflex sensitivity measured by the phenylephrine pressor test in patients with carotid sinus and sick sinus syndromes. ( Chan, SL; Dehn, TC; Morley, CA; Perrins, EJ; Sutton, R, 1984) |
| "A serum sickness-like syndrome developed in a 38-year-old woman with a history of drug allergy who had been taking propranolol hydrochloride (Inderal) for four days." | 3.66 | Serum sickness-like syndrome associated with propranolol therapy. ( Mintzer, DL; Piszczek, JE; Yen, MC, 1983) |
| "In an attempt to elucidate the ECG changes associated with the SCMS, we have applied the propranolol test in 35 of our patients suffering from this syndrome." | 3.65 | Adrenergic beta blockade and ECG changes in the systolic click murmur syndrome. ( Abinader, EG, 1976) |
| " Exacerbating factors, including diuretic-induced hypokalemia and the concomitant administration of perphenazine, were present." | 3.65 | Asymptomatic idiopathic syndrome of prolonged Q-T interval in a 45-year-old woman. Ventricular tachyarrhythmias precipitated by hypokalemia and therapy with amitriptyline and prephenazine. ( Bahler, A; Pincus, J; Schneider, RR; Stimmel, B, 1977) |
| "Amitriptyline was effective in 46 out of 81 (56%) patients (P < 0." | 2.73 | Cyclic vomiting syndrome in children: experience with 181 cases from southern Iran. ( Dehghani, SM; Fallahi, GH; Haghighat, M; Nejabat, M; Rafie, SM, 2007) |
| "Infantile hemangiomas are common; but they are extremely heterogeneous and cause a range of complications depending on their morphology, size, or location." | 2.58 | Infantile Hemangiomas in the Head and Neck Region. ( Adams, DM; Ricci, KW, 2018) |
| "Abdominal pain secondary to migraine is an unrecognized cause of abdominal pain in children with NF1 and may be more common than anatomic causes of abdominal pain in children with NF1." | 2.41 | Abdominal migraine in children with neurofibromatosis type 1: a case series and review of gastrointestinal involvement in NF1. ( Bousvaros, A; Heuschkel, R; Kim, S; Korf, B; Schneider, G, 2001) |
| "Propranolol was the most effective agent with reported benefit in four of six cases, other antimigraine agents were deemed effective in two of seven cases." | 2.39 | Prophylactic therapy in cyclic vomiting syndrome. ( Forbes, D; Withers, G, 1995) |
| "Migraine is a hereditary disorder afflicting 5 per cent of school-age children." | 2.37 | Migraine in children. ( Fenichel, GM, 1985) |
| "Propranolol can produce a significant reduction of myocardial oxygen consumption and may redirect coronary flow to ischemic areas." | 2.35 | Unstable angina pectoris. ( Cairns, JA; Fantus, IG; Klassen, GA, 1976) |
| "Prior to propranolol the systemic treatment for haemangiomas was prednisolone and then the concern was the opposite, namely hypertension." | 1.42 | Propranolol and prednisolone combination for the treatment of segmental haemangioma in PHACES syndrome. ( Batul Syed, S; Gnarra, M; Harper, J; Solman, L, 2015) |
| "Gorham-Stout syndrome is a rare disorder characterized by progressive osteolysis that leads to the disappearance of bone." | 1.39 | Gorham-Stout syndrome affecting the temporal bone with cerebrospinal fluid leakage. ( Kitamuara, M; Maekawa, T; Miyazaki, O; Morimoto, N; Morota, N; Nakazawa, A; Nishina, S; Ogiwara, H, 2013) |
| "PHACE syndrome is a neurocutaneous disorder with large facial segmental hemangionas associated with anomalies of the brain, eye, heart and aorta." | 1.37 | Use of propranolol for treatment of hemangiomas in PHACE syndrome. ( Deming, D; Hopper, A; Merritt, TA; Ninnis, J; Solomon, T, 2011) |
| "Cyclic-vomiting syndrome is probably a common but often not recognised syndrome." | 1.33 | [Cyclic vomiting in children]. ( Fontijn, JR; Rövekamp, MH; van der Woerd, WL; van Diemen-Steenvoorde, JA, 2006) |
| "So far there are no cases reported of vitamin C deficiency in ITS." | 1.33 | Scurvy in infantile tremor syndrome. ( Hakeem, MA; Patil, MM; Ratageri, VH; Shepur, TA, 2005) |
| "A 37 year old patient with chronic active hepatitis progressing to cirrhosis presented with increasing breathlessness and was found to be hypoxic with finger clubbing." | 1.29 | Spontaneous improvement in a patient with the hepatopulmonary syndrome assessed by serial exercise tests. ( Dalton, HR; Fernando, SS; Joseph, A; Saunders, KB, 1994) |
| "Slit ventricle syndrome is characterized by chronic or recurring headaches associated with subnormal ventricular volume in patients who have undergone shunt treatment for hydrocephalus." | 1.28 | Antimigraine treatment for slit ventricle syndrome. ( Cogen, PH; Edwards, MS; Obana, WG; Raskin, NH; Szymanski, JA, 1990) |
| "Treatment with propranolol and implantation of a demand pacemaker has prevented further attacks." | 1.27 | Asystole in the prolonged QT syndrome. ( Arnold, R; Rennie, JM, 1984) |
| "The syndrome was familial in five patients and idiopathic in 10." | 1.27 | Electrophysiologic testing in patients with the long QT syndrome. ( Bhandari, AK; Mason, J; Morady, F; Scheinman, MM; Shapiro, WA; Shen, EN, 1985) |
| "Symptoms suggestive of transient cerebral ischemia prompted an angiographic study which demonstrated both normal cerebral circulation and an enormous increase in the size of thyroid vasculature." | 1.26 | Thyroid steal syndrome? ( Fisher, LH; Pont, A, 1982) |
| "Ventricular arrhythmias have to be considered as reason for the attacks." | 1.26 | [Romano Ward syndrome]. ( Riedinger, I; Schlemmer, M; Stiskal, A; Wimmer, M, 1980) |
| "The Romano-Ward syndrome is very rare as hereditary disease." | 1.25 | QT prolongation and syncopal attacks. A case of the Romano-Ward syndrome. ( Hanazono, N; Tanaka, R, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 77 (63.11) | 18.7374 |
| 1990's | 12 (9.84) | 18.2507 |
| 2000's | 11 (9.02) | 29.6817 |
| 2010's | 20 (16.39) | 24.3611 |
| 2020's | 2 (1.64) | 2.80 |
| Authors | Studies |
|---|---|
| Kleinman, EP | 1 |
| Blei, F | 1 |
| Adams, D | 1 |
| Greenberger, S | 1 |
| Zamil, DH | 1 |
| Fernandez, JK | 1 |
| Brown, DN | 1 |
| Kralik, SF | 1 |
| Herd, TJ | 1 |
| Richards, JR | 1 |
| Dutczak, O | 1 |
| Maglie, R | 1 |
| Caproni, M | 1 |
| Adams, DM | 1 |
| Ricci, KW | 1 |
| Deuschl, G | 1 |
| Berg, D | 1 |
| Hernández, CR | 1 |
| Loza, SM | 1 |
| López, RL | 1 |
| Del Mar García Romero, M | 1 |
| Ramtohul, P | 1 |
| Beylerian, M | 1 |
| Dambricourt, L | 1 |
| Matonti, F | 1 |
| Denis, D | 1 |
| Banganho, D | 1 |
| Oliveira, I | 1 |
| Machado, C | 1 |
| Póvoas, M | 1 |
| Léauté-Labrèze, C | 1 |
| Morimoto, N | 1 |
| Ogiwara, H | 1 |
| Miyazaki, O | 1 |
| Kitamuara, M | 1 |
| Nishina, S | 1 |
| Nakazawa, A | 1 |
| Maekawa, T | 1 |
| Morota, N | 1 |
| Ng, SY | 1 |
| Kader Ibrahim, SB | 1 |
| Noyes, AM | 1 |
| Kluger, J | 1 |
| Horváth, K | 1 |
| Aschermann, Z | 1 |
| Komoly, S | 1 |
| Kovács, A | 1 |
| Kovács, N | 1 |
| Gnarra, M | 1 |
| Solman, L | 1 |
| Harper, J | 1 |
| Batul Syed, S | 1 |
| Thomas, RM | 1 |
| Gobbur, RH | 1 |
| Yu, X | 1 |
| Zhang, J | 1 |
| Wu, Z | 1 |
| Liu, M | 1 |
| Chen, R | 1 |
| Gu, Y | 1 |
| Li, M | 1 |
| Yao, Z | 1 |
| Piccolo, V | 1 |
| Moscarella, E | 1 |
| Ametrano, O | 1 |
| Picciocchi, R | 1 |
| Russo, T | 1 |
| Ozden, I | 1 |
| Imura, S | 1 |
| Gruber, RP | 1 |
| Roberts, C | 1 |
| Schooler, W | 1 |
| Pitman, RK | 1 |
| Ye, YM | 1 |
| Kim, JE | 1 |
| Kim, JH | 1 |
| Choi, GS | 1 |
| Park, HS | 1 |
| Hofman, N | 1 |
| Tan, HL | 1 |
| Alders, M | 1 |
| van Langen, IM | 1 |
| Wilde, AA | 1 |
| Shaikh, AG | 1 |
| Zee, DS | 1 |
| Optican, LM | 1 |
| Miura, K | 1 |
| Ramat, S | 1 |
| Leigh, RJ | 1 |
| Solomon, T | 1 |
| Ninnis, J | 1 |
| Deming, D | 1 |
| Merritt, TA | 1 |
| Hopper, A | 1 |
| Nademanee, K | 1 |
| Veerakul, G | 1 |
| Mower, M | 1 |
| Likittanasombat, K | 1 |
| Krittayapong, R | 1 |
| Bhuripanyo, K | 1 |
| Sitthisook, S | 1 |
| Chaothawee, L | 1 |
| Lai, MY | 1 |
| Azen, SP | 1 |
| Aouate, P | 1 |
| Clerc, J | 1 |
| Viard, P | 1 |
| Seoud, J | 1 |
| Gaikwad, RV | 1 |
| Gaonkar, RK | 1 |
| Jadhav, SA | 1 |
| Thorat, VM | 1 |
| Jadhav, JH | 1 |
| Balsara, JJ | 1 |
| Ratageri, VH | 1 |
| Shepur, TA | 1 |
| Patil, MM | 1 |
| Hakeem, MA | 1 |
| van der Woerd, WL | 1 |
| Fontijn, JR | 1 |
| Rövekamp, MH | 1 |
| van Diemen-Steenvoorde, JA | 1 |
| Haghighat, M | 1 |
| Rafie, SM | 1 |
| Dehghani, SM | 1 |
| Fallahi, GH | 1 |
| Nejabat, M | 1 |
| Golikov, AP | 1 |
| Vaniev, SB | 1 |
| Berestov, AA | 1 |
| Maĭorov, NI | 1 |
| Orlov, AI | 1 |
| Beder, SD | 1 |
| Gutgesell, HP | 1 |
| Mullins, CE | 1 |
| McNamara, DG | 1 |
| Rennie, JM | 1 |
| Arnold, R | 1 |
| Roach, NE | 1 |
| George, MD | 1 |
| Skoch, MG | 1 |
| Van Winter, JT | 1 |
| Stickler, GB | 1 |
| Goetz, CG | 1 |
| Tanner, CM | 1 |
| Klawans, HL | 1 |
| Packer, DL | 1 |
| Coltorti, F | 1 |
| Smith, MS | 1 |
| Bardy, GH | 1 |
| Benson, DW | 1 |
| Edwards, SB | 1 |
| German, LD | 1 |
| Morley, CA | 1 |
| Dehn, TC | 1 |
| Perrins, EJ | 1 |
| Chan, SL | 1 |
| Sutton, R | 1 |
| Strasberg, B | 1 |
| Welch, W | 1 |
| Palileo, E | 1 |
| Swiryn, S | 1 |
| Bauernfeind, R | 1 |
| Rosen, KM | 2 |
| Yen, MC | 1 |
| Piszczek, JE | 1 |
| Mintzer, DL | 1 |
| La Selve, P | 1 |
| Louis, JJ | 1 |
| Feit, JP | 1 |
| Guibaud, P | 1 |
| Larbre, F | 1 |
| Medak, R | 1 |
| Benumof, JL | 1 |
| Mathewson, MA | 1 |
| Pont, A | 1 |
| Fisher, LH | 1 |
| Borrello, G | 1 |
| Froiio, D | 1 |
| Durante, S | 1 |
| Mechler, F | 1 |
| Mastaglia, FL | 1 |
| Haggith, J | 1 |
| Gardner-Medwin, D | 1 |
| de Jong, PE | 1 |
| Donker, AJ | 1 |
| van der Wall, E | 1 |
| Erkelens, DW | 1 |
| van der Hem, GK | 1 |
| Doorenbos, H | 1 |
| Stiskal, A | 1 |
| Schlemmer, M | 1 |
| Riedinger, I | 1 |
| Wimmer, M | 1 |
| Mitsutake, A | 1 |
| Takeshita, A | 1 |
| Kuroiwa, A | 1 |
| Nakamura, M | 1 |
| Vieweg, V | 1 |
| Pandurangi, A | 1 |
| Levenson, J | 1 |
| Silverman, J | 1 |
| Saunders, KB | 1 |
| Fernando, SS | 1 |
| Dalton, HR | 1 |
| Joseph, A | 1 |
| Forbes, D | 1 |
| Withers, G | 1 |
| van Dam, GM | 1 |
| Reisman, Y | 1 |
| van Wieringen, K | 1 |
| Nozawa, T | 1 |
| Inoue, H | 1 |
| Worawattanakul, M | 1 |
| Rhoads, JM | 1 |
| Lichtman, SN | 1 |
| Ulshen, MH | 1 |
| Bariciak, MD | 1 |
| Nichols, BD | 1 |
| Sumiyoshi, M | 1 |
| Nakata, Y | 1 |
| Mineda, Y | 1 |
| Yasuda, M | 1 |
| Nakazato, Y | 1 |
| Yamaguchi, H | 1 |
| Gordon, N | 1 |
| Sandroni, P | 1 |
| Novak, V | 2 |
| Opfer-Gehrking, TL | 2 |
| Huck, CA | 1 |
| Low, PA | 2 |
| Gordon, VM | 1 |
| Heuschkel, R | 1 |
| Kim, S | 1 |
| Korf, B | 1 |
| Schneider, G | 1 |
| Bousvaros, A | 1 |
| Kabes, J | 2 |
| Dostal, T | 2 |
| Taussigová, D | 1 |
| Kabesová, L | 1 |
| Franchi, F | 1 |
| Michelucci, A | 1 |
| Brat, A | 1 |
| Arcangeli, C | 1 |
| Santoro, G | 1 |
| Padeletti, L | 1 |
| Fantini, F | 1 |
| Hilwig, RW | 1 |
| Topliss, D | 1 |
| Bond, R | 1 |
| Helson, L | 1 |
| Duque, L | 1 |
| Fushimi, H | 1 |
| Kobayashi, Y | 1 |
| Koyama, T | 1 |
| Miyata, M | 1 |
| Yamada, T | 1 |
| Matsuyuki, Y | 1 |
| Sugase, T | 1 |
| Shima, K | 1 |
| Tarui, S | 1 |
| Il'ina, NA | 1 |
| Poliakova, NF | 1 |
| Khokhlov, AP | 1 |
| Frandsen, PJ | 1 |
| Mikkelsen, B | 1 |
| Frisch, P | 1 |
| Hsieh, YY | 1 |
| Lee, YS | 1 |
| Chang, FZ | 1 |
| Lien, WP | 1 |
| Flemma, RJ | 1 |
| Staller, B | 1 |
| Baudouy, P | 1 |
| Andreassian, B | 1 |
| Attuel, P | 1 |
| Greze, M | 1 |
| Soulie, J | 1 |
| Fruchaud, J | 1 |
| Ahmad, S | 1 |
| Sheikh, AI | 1 |
| Meeran, MK | 1 |
| Offerhaus, L | 1 |
| von Zerssen, D | 1 |
| Cording, C | 1 |
| Joorabchi, B | 1 |
| Seipel, L | 1 |
| Breithardt, G | 1 |
| Döhring, HP | 1 |
| Kałuzna, J | 1 |
| Kozłowski, JW | 1 |
| Zebrowski, A | 1 |
| Crampton, RS | 1 |
| Wei, JY | 1 |
| Bulkley, BH | 1 |
| Schaeffer, AH | 1 |
| Greene, HL | 1 |
| Reid, PR | 1 |
| Ovsyshcher, IA | 1 |
| Gueron, M | 1 |
| Park, MK | 1 |
| Guntheroth, WG | 1 |
| Cairns, JA | 1 |
| Fantus, IG | 1 |
| Klassen, GA | 1 |
| Gorlin, R | 2 |
| Schneider, RR | 1 |
| Bahler, A | 1 |
| Pincus, J | 1 |
| Stimmel, B | 1 |
| Brodsky, M | 1 |
| Wu, D | 1 |
| Denes, P | 1 |
| Josephson, ME | 1 |
| Kastor, JA | 1 |
| Shappell, SD | 2 |
| Marshall, CE | 2 |
| Roy, PR | 1 |
| Emanuel, R | 1 |
| Ismail, SA | 1 |
| El Tayib, MH | 1 |
| Crawford, MH | 1 |
| Karliner, JS | 1 |
| O'Rourke, RA | 1 |
| Friedman, WF | 1 |
| Hanazono, N | 1 |
| Tanaka, R | 1 |
| Abinader, EG | 1 |
| Chaundron, JM | 1 |
| Heller, F | 1 |
| Van den Berghe, HB | 1 |
| LeBacq, EG | 1 |
| Montorsi, P | 1 |
| Fabbiocchi, F | 1 |
| Loaldi, A | 1 |
| Annoni, L | 1 |
| Polese, A | 1 |
| De Cesare, N | 1 |
| Guazzi, MD | 1 |
| Pericić, D | 1 |
| Mück-Seler, D | 1 |
| Obana, WG | 1 |
| Raskin, NH | 1 |
| Cogen, PH | 1 |
| Szymanski, JA | 1 |
| Edwards, MS | 1 |
| Jacquet, Y | 1 |
| Bhandari, AK | 1 |
| Shapiro, WA | 1 |
| Morady, F | 1 |
| Shen, EN | 1 |
| Mason, J | 1 |
| Scheinman, MM | 1 |
| Reik, L | 1 |
| Guzé, BH | 1 |
| Baxter, LR | 1 |
| Ferrini, D | 1 |
| Bugiardini, R | 1 |
| Galvani, M | 1 |
| Gridelli, C | 1 |
| Tollemeto, D | 1 |
| Puddu, P | 1 |
| Lenzi, S | 1 |
| Fenichel, GM | 1 |
| Andermann, E | 1 |
| Andermann, F | 1 |
| Carpenter, S | 1 |
| Wolfe, LS | 1 |
| Nelson, R | 1 |
| Patry, G | 1 |
| Boileau, J | 1 |
| Mohr, JP | 1 |
| Duhigg, WJ | 1 |
| Streeten, DH | 1 |
| Kerr, CB | 1 |
| Kerr, LP | 1 |
| Prior, JC | 1 |
| Dalakos, TG | 1 |
| Fischl, SJ | 1 |
| Herman, MV | 1 |
| Takamori, M | 1 |
| Ishii, N | 1 |
| Mori, M | 1 |
| Yasue, H | 1 |
| Touyama, M | 1 |
| Shimamoto, M | 1 |
| Kato, H | 1 |
| Tanaka, S | 1 |
| Ticzon, AR | 1 |
| Whalen, RW | 1 |
| Jacovella, C | 1 |
| Santini, M | 1 |
| Masini, V | 1 |
| Reyes, AJ | 1 |
| Csanády, M | 1 |
| Kiss, Z | 1 |
| Leon-Sotomayor, LA | 1 |
| Schwartz, GJ | 1 |
| Cornfeld, D | 1 |
| Schneider, P | 1 |
| Schöne, D | 1 |
| Bock, K | 1 |
| Griegel, B | 1 |
| Petelenz, T | 1 |
| Langauer-Lewowicka, H | 1 |
| Górkowa, H | 1 |
| Kubicka, J | 1 |
| Illg, W | 1 |
| Müller, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Genetic Analysis of Heart Channelopathies in Brazilian Patients and Their Relatives[NCT04832126] | 100 participants (Anticipated) | Observational | 2018-01-01 | Recruiting | |||
| A Double-Blinded, Placebo-Controlled Study To Assess Hemodynamic Changes, Orthostatic Tolerance, Out-Patient Fatigue And Quality Of Life In Neuropathic And Non-Neuropathic POTS Patients In Response To Adrenoreceptor Agonist And Antagonist[NCT03070730] | Phase 1/Phase 2 | 8 participants (Actual) | Interventional | 2011-08-15 | Terminated (stopped due to Recruitment was slow and subjects declined participation after signing the ICF.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT03070730)
Timeframe: 1 week after first intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
(NCT03070730)
Timeframe: 1 week after second intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
(NCT03070730)
Timeframe: 1 week after third intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
A 14 item self-report questionnaire. Subjects respond on a continuum of 1 to 4 questions evaluating fatigue intensity while distinguishing physical from mental fatigue. (NCT03070730)
Timeframe: 2 weeks after first intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
A 14 item self-report questionnaire. Subjects respond on a continuum of 1 to 4 questions evaluating fatigue intensity while distinguishing physical from mental fatigue. (NCT03070730)
Timeframe: 2 weeks after second intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
A 14 item self-report questionnaire. Subjects respond on a continuum of 1 to 4 questions evaluating fatigue intensity while distinguishing physical from mental fatigue. (NCT03070730)
Timeframe: up to 3 days after randomization
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
(NCT03070730)
Timeframe: 1 week after first intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
(NCT03070730)
Timeframe: 1 week after second intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
(NCT03070730)
Timeframe: 1 week after third intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
Maximal postural tachycardia is the maximum heart rate during a 20-min tilt table test. (NCT03070730)
Timeframe: Up to 3 days after randomization
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
(NCT03070730)
Timeframe: 1 week after first intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
(NCT03070730)
Timeframe: 1 week after second intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
(NCT03070730)
Timeframe: 1 week after third intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
"Measures of follow up testing will be the scores on the physical functioning subscale of the 7 item patient global impression of change with items anchored by :very much better to very much worse." (NCT03070730)
Timeframe: 1 week after first intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
"Measures of follow up testing will be the scores on the physical functioning subscale of the 7 item patient global impression of change with items anchored by :very much better to very much worse." (NCT03070730)
Timeframe: 1 week after second intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
"Measures of follow up testing will be the scores on the physical functioning subscale of the 7 item patient global impression of change with items anchored by :very much better to very much worse." (NCT03070730)
Timeframe: 1 week after third intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
Measures of follow up testing will be the scores on the physical functioning subscale of the Hospital Anxiety and Depression Scales. (NCT03070730)
Timeframe: 1 week after first intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
Measures of follow up testing will be the scores on the physical functioning subscale of the Hospital Anxiety and Depression Scales. (NCT03070730)
Timeframe: 1 week after second intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
Measures of follow up testing will be the scores on the physical functioning subscale of the Hospital Anxiety and Depression Scales. (NCT03070730)
Timeframe: 1 week after third intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
Measures of follow up testing will be the scores on the physical functioning subscale of the Checklist Individual Strength (CIS). (NCT03070730)
Timeframe: 1 week after first intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
Measures of follow up testing will be the scores on the physical functioning subscale of the Checklist Individual Strength (CIS). (NCT03070730)
Timeframe: 1 week after second intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
Measures of follow up testing will be the scores on the physical functioning subscale of the Checklist Individual Strength (CIS). (NCT03070730)
Timeframe: 1 week after third intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
Measures of follow up testing will be the scores on the physical functioning subscale of the EuroQOL. (NCT03070730)
Timeframe: 1 week after first intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
Measures of follow up testing will be the scores on the physical functioning subscale of the EuroQOL. (NCT03070730)
Timeframe: 1 week after second intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
Measures of follow up testing will be the scores on the physical functioning subscale of the EuroQOL. (NCT03070730)
Timeframe: 1 week after third intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
Measures of follow up testing will be the scores on the physical functioning subscale of the Fatigue Severity Scale. (NCT03070730)
Timeframe: 1 week after first intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
Measures of follow up testing will be the scores on the physical functioning subscale of the Fatigue Severity Scale. (NCT03070730)
Timeframe: 1 week after second intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
Measures of follow up testing will be the scores on the physical functioning subscale of the Fatigue Severity Scale. (NCT03070730)
Timeframe: 1 week after third intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
Measures of follow up testing will be the scores on the physical functioning subscale of the Multidimensional Fatigue Inventory (MFI). (NCT03070730)
Timeframe: 1 week after first intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
Measures of follow up testing will be the scores on the physical functioning subscale of the Multidimensional Fatigue Inventory (MFI). (NCT03070730)
Timeframe: 1 week after second intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
Measures of follow up testing will be the scores on the physical functioning subscale of the Multidimensional Fatigue Inventory (MFI). (NCT03070730)
Timeframe: 1 week after third intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
Measures of follow up testing will be the scores on the physical functioning subscale of the Orthostatic Intolerance Questionnaire. (NCT03070730)
Timeframe: 1 week after first intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
Measures of follow up testing will be the scores on the physical functioning subscale of the Orthostatic Intolerance Questionnaire. (NCT03070730)
Timeframe: 1 week after second intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
Measures of follow up testing will be the scores on the physical functioning subscale of the Orthostatic Intolerance Questionnaire. (NCT03070730)
Timeframe: 1 week after third intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
Measures of follow up testing will be the scores on the physical functioning subscale of the SF-36 questionnaire. (NCT03070730)
Timeframe: 1 week after first intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
Measures of follow up testing will be the scores on the physical functioning subscale of the SF-36 questionnaire. (NCT03070730)
Timeframe: 1 week after second intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
Measures of follow up testing will be the scores on the physical functioning subscale of the SF-36 questionnaire. (NCT03070730)
Timeframe: 1 week after third intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
(NCT03070730)
Timeframe: 1 week after first intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
(NCT03070730)
Timeframe: 1 week after second intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
(NCT03070730)
Timeframe: 1 week after third intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
Maximal postural tachycardia is the maximum heart rate during a 20-min tilt table test. (NCT03070730)
Timeframe: 2 weeks after first intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
Maximal postural tachycardia is the maximum heart rate during a 20-min tilt table test. (NCT03070730)
Timeframe: 2 weeks after second intervention
| Intervention | () |
|---|---|
| Atenolol | 0 |
| Placebos | 0 |
| Droxidopa | 0 |
21 reviews available for propranolol and Syndrome
| Article | Year |
|---|---|
Sirolimus for diffuse intestinal infantile hemangioma with PHACE features: systematic review.
Topics: Aortic Coarctation; Eye Abnormalities; Female; Hemangioma; Hemangioma, Capillary; Humans; Infant; Pr | 2023 |
Infantile Hemangiomas in the Head and Neck Region.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Head and Neck Neoplasms; Hemangioma; Humans; Infa | 2018 |
[Essential tremor: state of the art].
Topics: Age Factors; Deep Brain Stimulation; Diagnosis, Differential; Essential Tremor; Genetic Predispositi | 2018 |
[Infantile hemangioma: update and treatment].
Topics: Abnormalities, Multiple; Adrenergic beta-Antagonists; Early Medical Intervention; Esthetics; Follow- | 2013 |
[Treatment of tardive syndromes].
Topics: Amantadine; Antipsychotic Agents; Botulinum Toxins; Central Nervous System Agents; Cholinergic Antag | 2014 |
LUMBAR syndrome: A case manifesting as cutaneous infantile hemangiomas of the lower extremity, perineum and gluteal region, and a review of published work.
Topics: Abnormalities, Multiple; Adrenergic beta-Antagonists; Biopsy; Buttocks; Female; Hemangioma; Humans; | 2017 |
The consulting psychiatrist and the polydipsia-hyponatremia syndrome in schizophrenia.
Topics: Angiotensin II; Anti-Inflammatory Agents, Non-Steroidal; Antipsychotic Agents; Carbamazepine; Cognit | 1994 |
Prophylactic therapy in cyclic vomiting syndrome.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Humans; Male; Migraine Disorders; Periodicity; P | 1995 |
Hypokalaemic thyrotoxic periodic paralysis: case report and review of an Oriental syndrome.
Topics: Adrenergic beta-Antagonists; Adult; Anti-Inflammatory Agents; Antithyroid Agents; Humans; Hypokalemi | 1996 |
[Treatment with beta-blockers in patients with acute coronary syndrome].
Topics: Acute Disease; Adrenergic beta-Antagonists; Angina, Unstable; Atenolol; Clinical Trials as Topic; Co | 1998 |
Cataracts in systemic diseases and syndromes.
Topics: Amiodarone; Cataract; Cataract Extraction; Diabetes Complications; Diabetic Retinopathy; Female; Hum | 1995 |
Episodic dyscontrol syndrome.
Topics: Affect; Anti-Anxiety Agents; Child; Child Behavior Disorders; Humans; Male; Propranolol; Rage; Syndr | 1999 |
Abdominal migraine in children with neurofibromatosis type 1: a case series and review of gastrointestinal involvement in NF1.
Topics: Abdominal Pain; Adrenergic beta-Antagonists; Child; Child, Preschool; Female; Humans; Male; MEDLINE; | 2001 |
[Sino-atrial disease (sick sinus syndrome). I. Recent nosographic and electrophysiological diagnostic acquistions].
Topics: Adrenergic beta-Agonists; Arrhythmias, Cardiac; Atropine; Bradycardia; Cardiac Pacing, Artificial; E | 1979 |
Cardiac arrhythmias in the dog: detection and treatment.
Topics: Animals; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Bradycardia; Cardiac Complexe | 1976 |
[Therapy and differential therapy with beta sympathicolytic drugs].
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Arrhythmias, Cardiac; Cardiomyopathy, Hype | 1975 |
Unstable angina pectoris.
Topics: Angina Pectoris; Angiocardiography; Anticoagulants; Hemodynamics; Humans; Myocardial Infarction; Myo | 1976 |
Hereditary prolongation of the Q-T interval. Genetic observations and management in three families with twelve affected members.
Topics: Adolescent; Child; Electrocardiography; Female; Heart Diseases; Humans; Male; Pacemaker, Artificial; | 1976 |
Headaches in pregnancy.
Topics: Adult; Ergotamine; Ergotamines; Female; Headache; Humans; Postpartum Period; Pregnancy; Pregnancy Co | 1988 |
Migraine in children.
Topics: Adolescent; Basilar Artery; Brain Injuries; Cerebrovascular Circulation; Child; Child, Preschool; Co | 1985 |
Refractory supraventricular tachycardias.
Topics: Atrial Fibrillation; Atrial Flutter; Bradycardia; Digitalis Glycosides; Electric Countershock; Elect | 1973 |
5 trials available for propranolol and Syndrome
| Article | Year |
|---|---|
Preventing postsurgical dissatisfaction syndrome after rhinoplasty with propranolol: a pilot study.
Topics: Anxiety; Body Image; Depression; Double-Blind Method; Humans; Patient Satisfaction; Pilot Projects; | 2009 |
Defibrillator Versus beta-Blockers for Unexplained Death in Thailand (DEBUT): a randomized clinical trial.
Topics: Adrenergic beta-Antagonists; Adult; Arrhythmias, Cardiac; Death, Sudden; Defibrillators, Implantable | 2003 |
Cyclic vomiting syndrome in children: experience with 181 cases from southern Iran.
Topics: Adolescent; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Amitriptyline; Child; Child, | 2007 |
[Effects of Atenolol and Propranolol on sinus node and intracardiac conduction in man (author's transl)].
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Atenolol; Bundle of His; Electrocardiography; Female; Heart | 1977 |
[Opposing effects of propranolol and diltiazem on the angina threshold during an exercise test in patients with syndrome X].
Topics: Adult; Angina Pectoris; Benzazepines; Blood Pressure; Cardiac Pacing, Artificial; Coronary Vessels; | 1986 |
96 other studies available for propranolol and Syndrome
| Article | Year |
|---|---|
Intracranial hemangioma-associated cranial nerve VII palsy treated with propranolol in an infant with possible PHACE syndrome.
Topics: Brain Neoplasms; Facial Nerve; Facial Paralysis; Female; Hemangioma; Humans; Infant; Propranolol; Sy | 2022 |
Propranolol Treatment of Cannabinoid Hyperemesis Syndrome: A Case Report.
Topics: Adrenergic beta-Antagonists; Adult; Cannabinoids; Humans; Male; Nausea; Propranolol; Syndrome; Vomit | 2017 |
A case of blood sweating: hematohidrosis syndrome.
Topics: Diagnosis, Differential; Face; Female; Hemorrhage; Humans; Propranolol; Rare Diseases; Skin; Sweatin | 2017 |
Red Ear Syndrome in a Pediatric Patient.
Topics: Adrenergic beta-Antagonists; Child; Diagnosis, Differential; Ear Diseases; Ear, External; Erythema; | 2018 |
Secondary Congenital Glaucoma Associated With Retro-orbital Infantile Hemangioma: A Masquerade Syndrome.
Topics: Diagnosis, Differential; Female; Glaucoma; Hemangioma; Humans; Hydrophthalmos; Infant; Intraocular P | 2019 |
Microphthalmia with linear skin defects syndrome (MIDAS).
Topics: Abnormalities, Multiple; Anti-Arrhythmia Agents; Chromosomes, Human, X; Female; Genetic Diseases, X- | 2019 |
Gorham-Stout syndrome affecting the temporal bone with cerebrospinal fluid leakage.
Topics: Cerebrospinal Fluid Rhinorrhea; Child; Combined Modality Therapy; Female; Follow-Up Studies; Humans; | 2013 |
A Case of PHACES Syndrome with Successful Treatment of Facial Haemangioma With Propranolol.
Topics: Hemangioma; Humans; Infant; Propranolol; Syndrome | 2013 |
A tale of two syndromes: Lyme disease preceding postural orthostatic tachycardia syndrome.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Diet, Gluten-Free; Female; Fluid Therapy; Humans; Lyme Di | 2015 |
Propranolol and prednisolone combination for the treatment of segmental haemangioma in PHACES syndrome.
Topics: Abnormalities, Multiple; Adrenergic beta-Antagonists; Antineoplastic Agents, Hormonal; Blepharoptosi | 2015 |
Infantile Tremor Syndrome.
Topics: Humans; Infant; Infant Nutrition Disorders; Male; Propranolol; Syndrome; Tremor; Vitamins | 2016 |
Image Gallery: PELVIS syndrome.
Topics: Antineoplastic Agents; Female; Hemangioma; Humans; Infant; Magnetic Resonance Imaging; Meningomyeloc | 2017 |
Somatostatin and propranolol for the treatment of small-for-size syndrome after liver transplantation.
Topics: Cardiovascular Agents; Humans; Liver Diseases; Liver Transplantation; Living Donors; Organ Size; Pro | 2008 |
Propylthiouracil-induced DRESS syndrome confirmed by a positive patch test.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Adult; Anti-Inflammatory Agents; Antithyroid A | 2010 |
Active cascade screening in primary inherited arrhythmia syndromes: does it lead to prophylactic treatment?
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cause of Death; Chi-Square Distribution; | 2010 |
The effects of ion channel blockers validate the conductance-based model of saccadic oscillations.
Topics: Case-Control Studies; Ethosuximide; Humans; Ion Channels; Models, Biological; Models, Neurological; | 2011 |
Use of propranolol for treatment of hemangiomas in PHACE syndrome.
Topics: Abnormalities, Multiple; Adrenergic beta-Antagonists; Facial Neoplasms; Female; Hemangioma; Humans; | 2011 |
Propranolol intoxication revealing a Brugada syndrome.
Topics: Adrenergic beta-Antagonists; Adult; Atropine; Bundle-Branch Block; Death, Sudden, Cardiac; Electroca | 2005 |
Involvement of central serotonergic systems in dextromethorphan-induced behavioural syndrome in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antitussive Agents; Behavior, Animal; Buspirone; Ce | 2005 |
Scurvy in infantile tremor syndrome.
Topics: Age Factors; Ascorbic Acid; Ascorbic Acid Deficiency; Folic Acid; Humans; Infant; Iron; Male; Malnut | 2005 |
[Cyclic vomiting in children].
Topics: Adolescent; Adrenergic beta-Antagonists; Child; Female; Fluid Therapy; Humans; Periodicity; Proprano | 2006 |
A 66-year-old man has an unexpected low cardiac output syndrome during repeat myocardial revascularization.
Topics: Aged; Angina, Unstable; Anti-Arrhythmia Agents; Blood Pressure; Cardiac Output, Low; Cardiotonic Age | 1988 |
[Use of beta-adrenoblockaders in the therapy of the syndromes accompanying acute myocardial infarct].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Cardiac Output; Hemodynamics; Humans | 1981 |
Progression from hypertrophic obstructive cardiomyopathy to congestive cardiomyopathy in a child.
Topics: Adolescent; Cardiomegaly; Cardiomyopathy, Hypertrophic; Child; Female; Heart Failure; Humans; Long-T | 1982 |
Asystole in the prolonged QT syndrome.
Topics: Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Child, Preschool; Electrocardiography; Heart Arres | 1984 |
Propranolol for episodic dyscontrol syndrome.
Topics: Adult; Anger; Humans; Male; Mental Disorders; Propranolol; Rage; Syndrome | 1984 |
Panic attack syndrome.
Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Child; Fear; Humans; Hyperven | 1984 |
The pharmacology of olivopontocerebellar atrophy.
Topics: Adult; Amantadine; Atrophy; Baclofen; Brain Diseases; Carbidopa; Cerebellar Ataxia; Female; Humans; | 1984 |
Sudden death after left stellectomy in the long QT syndrome.
Topics: Adolescent; Arrhythmias, Cardiac; Death, Sudden; Electrocardiography; Female; Ganglia, Sympathetic; | 1984 |
Baroreflex sensitivity measured by the phenylephrine pressor test in patients with carotid sinus and sick sinus syndromes.
Topics: Aged; Blood Pressure; Carotid Sinus; Electrocardiography; Female; Humans; Male; Phenylephrine; Press | 1984 |
Familial inducible torsade de pointes with normal QT interval.
Topics: Adult; Death, Sudden; Electric Stimulation; Electrocardiography; Female; Heart Ventricles; Humans; P | 1983 |
Serum sickness-like syndrome associated with propranolol therapy.
Topics: Adult; Diagnosis, Differential; Drug Hypersensitivity; Female; Humans; Propranolol; Serum Sickness; | 1983 |
[A case of leprechaunism].
Topics: Abnormalities, Multiple; Adult; Blood Glucose; Dwarfism; Female; Glucagon; Humans; Infant, Newborn; | 1982 |
Perioperative management of the prolonged Q-T interval syndrome.
Topics: Adult; Anesthesia, General; Arrhythmias, Cardiac; Electrocardiography; Heart Rate; Humans; Intraoper | 1983 |
Prolapsed mitral valve syndrome.
Topics: Humans; Mitral Valve Prolapse; Propranolol; Quinidine; Syndrome | 1980 |
Thyroid steal syndrome?
Topics: Carotid Arteries; Cerebrovascular Circulation; Female; Humans; Hyperthyroidism; Ischemic Attack, Tra | 1982 |
[A case of Jervell-Lange-Nielsen syndrome (idiopathic syndrome of long Q-T)].
Topics: Arrhythmias, Cardiac; Child; Deafness; Electrocardiography; Female; Humans; Male; Propranolol; Synco | 1982 |
Adrenergic receptor responses of vascular smooth muscle in Becker dystrophy. A muscle blood flow study using the 133Xe clearance method.
Topics: Adult; Epinephrine; Female; Humans; Male; Middle Aged; Muscle, Smooth, Vascular; Muscles; Muscular A | 1980 |
Effect of indomethacin in two siblings with a renin-dependent hypertension, hyperaldosteronism and hypokalemia.
Topics: Adolescent; Adult; Angiotensin II; Drug Therapy, Combination; Female; Humans; Hyperaldosteronism; Hy | 1980 |
[Romano Ward syndrome].
Topics: Adult; Aged; Arrhythmias, Cardiac; Child; Electrocardiography; Female; Humans; Pedigree; Propranolol | 1980 |
Usefulness of the Valsalva maneuver in management of the long QT syndrome.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Electrocardiography; Female; Heart Rate; Humans; Male | 1981 |
Spontaneous improvement in a patient with the hepatopulmonary syndrome assessed by serial exercise tests.
Topics: Adult; Azathioprine; Exercise Test; Hepatitis, Chronic; Humans; Hypoxia; Liver Cirrhosis; Lung Disea | 1994 |
Abdominal migraine: prophylactic treatment and follow-up.
Topics: Abdominal Pain; Adolescent; Child; Child, Preschool; Cyproheptadine; Female; Gastrointestinal Agents | 1999 |
Analysis of heart rate variability during head-up tilt testing in a patient with idiopathic postural orthostatic tachycardia syndrome (POTS).
Topics: Adolescent; Anti-Arrhythmia Agents; Diagnostic Techniques, Cardiovascular; Electrocardiography; Foll | 1999 |
Mechanisms of blood pressure alterations in response to the Valsalva maneuver in postural tachycardia syndrome.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Blood Pressure; Cardiovascular Sys | 2000 |
Hemodynamic and symptomatic effects of acute interventions on tilt in patients with postural tachycardia syndrome.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Antihypertensive Agents; Clonidine; Female; Hemodynamics; | 2000 |
Proceedings: Clinical effects of beta-adrenergic blockers in psychiatry.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Anxiety; Depression; Humans; Mental Disorders; Middl | 1975 |
Acute brain syndrome after propranolol treatment.
Topics: Acute Disease; Aged; Female; Humans; Propranolol; Psychoses, Substance-Induced; Syndrome; Tremor | 1977 |
Acute brain syndrome after propranolol.
Topics: Brain; Child; Cognition Disorders; Confusion; Female; Humans; Hypertension; Myoclonus; Propranolol; | 1978 |
Endocrine function in a case of beta-adrenergic hyperdynamic circulatory state.
Topics: Arginine; Blood Glucose; Cyclic AMP; Female; Glucagon; Growth Hormone; Humans; Hypertension; Insulin | 1976 |
[Pathogenesis of creatinuria and aminoaciduria in neuromuscular diseases].
Topics: Adolescent; Adult; Amino Acids; Amyotrophic Lateral Sclerosis; Caffeine; Child; Child, Preschool; Cr | 1977 |
[Beta-adrenergic hyperactivity. A new clinical syndrome?].
Topics: Adult; Female; Humans; Isoproterenol; Nervous System Diseases; Propranolol; Receptors, Adrenergic; R | 1978 |
The Romano-Ward syndrome. A case report.
Topics: Adult; Arrhythmias, Cardiac; Electrocardiography; Female; Humans; Propranolol; Syncope; Syndrome | 1977 |
Integrated medical-surgical treatment of pre-infarction syndrome.
Topics: Adult; Aged; Angina Pectoris; Angiocardiography; Aortic Valve Stenosis; Coronary Artery Bypass; Deci | 1977 |
[Romano-Ward syndrome and left stellectomy. General review apropos of a recent case].
Topics: Adult; Arrhythmias, Cardiac; Deafness; Diagnosis, Differential; Drug Therapy, Combination; Electroca | 1977 |
Additional side effects of propranolol.
Topics: Humans; Male; Propranolol; Substance Withdrawal Syndrome; Syndrome | 1979 |
[Propranolol withdrawal syndrome].
Topics: Coronary Vessels; Humans; Platelet Aggregation; Propranolol; Substance Withdrawal Syndrome; Syndrome | 1979 |
The measurement of change in endogenous affective disorders.
Topics: Affect; Affective Symptoms; Circadian Rhythm; Depression; Dose-Response Relationship, Drug; Humans; | 1978 |
Expressions of the hyperventilation syndrome in childhood: studies in management, including an evaluation of the effectiveness of propranolol.
Topics: Adolescent; Affective Symptoms; Child; Child, Preschool; Evaluation Studies as Topic; Follow-Up Stud | 1977 |
[Prolonged Q-T syndrome. Clinical and therapeutic aspects].
Topics: Adult; Arrhythmias, Cardiac; Electrocardiography; Female; Humans; Male; Middle Aged; Propranolol; Sy | 1977 |
Another link between the left stellate ganglion and the long Q-T syndrome.
Topics: Adult; Arrhythmias, Cardiac; Electrocardiography; Female; Humans; Phenytoin; Propranolol; Stellate G | 1978 |
Mitral-valve prolapse syndrome and recurrent ventricular tachyarrhythmias: a malignant variant refractory to conventional drug therapy.
Topics: Adult; Aged; Aprindine; Arrhythmias, Cardiac; Electrocardiography; Female; Humans; Male; Middle Aged | 1978 |
Congenital QT interval prolongation. A review with a survey of three families.
Topics: Adult; Arrhythmias, Cardiac; Child; Digoxin; Female; Humans; Isoproterenol; Male; Pedigree; Proprano | 1978 |
Long Q-T syndrome: a preventable form of sudden death.
Topics: Adolescent; Child; Death, Sudden; Electrocardiography; Follow-Up Studies; Humans; Male; Pedigree; Pr | 1978 |
The syndromes of cardiac pain.
Topics: Angina Pectoris; Angina Pectoris, Variant; Cardiomyopathies; Coronary Angiography; Coronary Circulat | 1976 |
Asymptomatic idiopathic syndrome of prolonged Q-T interval in a 45-year-old woman. Ventricular tachyarrhythmias precipitated by hypokalemia and therapy with amitriptyline and prephenazine.
Topics: Amitriptyline; Bretylium Tosylate; Electrocardiography; Female; Heart Ventricles; Humans; Hypokalemi | 1977 |
Familial atrial tachyarrhythmia with short PR interval.
Topics: Adult; Arrhythmias, Cardiac; Digoxin; Electrocardiography; Female; Heart Atria; Humans; Male; Pedigr | 1977 |
Supraventricular tachycardia in Lown-Ganong-Levine syndrome: atrionodal versus intranodal reentry.
Topics: Adolescent; Adult; Atrioventricular Node; Cardiac Pacing, Artificial; Electrocardiography; Female; H | 1977 |
Ballooning posterior leaflet syndrome: syncope and sudden death.
Topics: Adult; Arrhythmias, Cardiac; Death, Sudden; Female; Heart Valve Diseases; Humans; Mitral Valve; Phen | 1975 |
Prolonged Q-T interval syndrome. Successful treatment with combined ventricular pacing and propanolol.
Topics: Adolescent; Arrhythmias, Cardiac; Cardiac Catheterization; Electrocardiography; Female; Heart Ventri | 1975 |
QT prolongation and syncopal attacks. A case of the Romano-Ward syndrome.
Topics: Adolescent; Electrocardiography; Female; Heart Diseases; Humans; Pedigree; Propranolol; Syncope; Syn | 1975 |
Proceedings: Lithium prophylaxis--psychiatric complications and their management by beta-adrenergic blockers.
Topics: Adult; Bipolar Disorder; Female; Humans; Lithium; Male; Middle Aged; Propranolol; Syndrome | 1975 |
Adrenergic beta blockade and ECG changes in the systolic click murmur syndrome.
Topics: Adolescent; Adult; Aged; Electrocardiography; Female; Heart; Heart Diseases; Heart Murmurs; Heart Ra | 1976 |
Attacks of ventricular fibrillation and unconsciousness in a patient with prolonged QT interval. A family study.
Topics: Adolescent; Electrocardiography; Female; Heart Diseases; Humans; Pedigree; Propranolol; Syndrome; Un | 1976 |
Coronary adrenergic hyperreactivity in patients with syndrome X and abnormal electrocardiogram at rest.
Topics: Adrenergic Fibers; Angina Pectoris; Blood Pressure; Cardiac Output; Cold Temperature; Coronary Circu | 1991 |
Do imipramine and dihydroergosine possess two components--one stimulating 5-HT1 and the other inhibiting 5-HT2 receptors?
Topics: Animals; Brain; Ergotamines; Imipramine; Male; Mice; Mice, Inbred CBA; Motor Activity; Piperidines; | 1990 |
Antimigraine treatment for slit ventricle syndrome.
Topics: Adult; Cerebral Ventricles; Cerebral Ventriculography; Cerebrospinal Fluid Shunts; Child, Preschool; | 1990 |
A dystonia-like syndrome after neuropeptide (MSH/ACTH) stimulation of the rat locus ceruleus.
Topics: Adrenocorticotropic Hormone; alpha-Methyltyrosine; Animals; Dose-Response Relationship, Drug; Dyston | 1988 |
Electrophysiologic testing in patients with the long QT syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Ch | 1985 |
The serotonin syndrome: case responsive to propranolol.
Topics: Adult; Bipolar Disorder; Female; Humans; Propranolol; Serotonin; Syndrome; Tryptophan | 1986 |
Action myoclonus-renal failure syndrome: a previously unrecognized neurological disorder unmasked by advances in nephrology.
Topics: Adult; Brain; Carbidopa; Electroencephalography; Electromyography; Female; Humans; Kidney Failure, C | 1986 |
Lacunar stroke.
Topics: Adult; Blood Pressure; Brain; Cerebrovascular Disorders; Diagnosis, Differential; Hemiplegia; Humans | 1986 |
Effects of propranolol and ataxic syndromes.
Topics: Ataxia; Female; Humans; Male; Middle Aged; Propranolol; Syndrome | 1985 |
Hyperbradykininism: a new orthostatic syndrome.
Topics: Adolescent; Adult; Blushing; Bradykinin; Carboxypeptidases; Child; Cyproheptadine; Female; Fludrocor | 1972 |
The intermediate coronary syndrome: clinical, angiographic and therapeutic aspects.
Topics: Adrenergic beta-Antagonists; Adult; Angiography; Blood Pressure; Clinical Enzyme Tests; Coronary Ang | 1973 |
The role of cyclic 3',5'-adenosine monophosphate in neuromuscular transmission.
Topics: Acetylcholine; Action Potentials; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Aminophylline | 1973 |
Role of autonomic nervous system in the pathogenesis of Prinzmetal's variant form of angina.
Topics: Adult; Angina Pectoris; Atropine; Blood Pressure; Coronary Vessels; Electrocardiography; Epinephrine | 1974 |
[Romano-Ward syndrome: description of 2 personal cases].
Topics: Electrocardiography; Female; Heart Auscultation; Heart Diseases; Humans; Middle Aged; Pedigree; Proc | 1973 |
Propranolol and the hyperactive carotid sinus reflex syndrome.
Topics: Carotid Sinus; Humans; Male; Middle Aged; Pressure; Propranolol; Reflex; Syndrome | 1973 |
Heritable Q-T prolongation without congenital deafness (Romano-Ward syndrome).
Topics: Adams-Stokes Syndrome; Adult; Deafness; Death, Sudden; Electrocardiography; Female; Heart Diseases; | 1973 |
Cardiac migraine--report of twelve cases.
Topics: Adolescent; Adult; Angina Pectoris; Angiocardiography; Coronary Disease; Diazepam; Diet Therapy; Ele | 1974 |
Letter: Propranolol in Bartter's syndrome.
Topics: Child; Diet; Humans; Hyperaldosteronism; Hypokalemia; Juxtaglomerular Apparatus; Kidney Diseases; Ma | 1974 |
Sudden death and the ballooning posterior leaflet syndrome. Detailed anatomic and histochemical investigation.
Topics: Adult; Aorta; Autopsy; Coronary Vessels; Death, Sudden; Electrocardiography; Female; Heart Auscultat | 1974 |
[The hereditary syndrome of QT-interval prolongation (Romano-Ward-Syndrome): differential diagnosis of syncopal attacks].
Topics: Adams-Stokes Syndrome; Adolescent; Adult; Autopsy; Death, Sudden; Diagnosis, Differential; Electroca | 1974 |
[Propranolol in vibration disease].
Topics: Adult; Evaluation Studies as Topic; Humans; Male; Middle Aged; Propranolol; Syndrome; Vibration | 1972 |
[Electrocardiographic changes in the hyperkinetic cardiac syndrome].
Topics: Adolescent; Adult; Dysautonomia, Familial; Electrocardiography; Female; Heart Diseases; Humans; Male | 1972 |